MedTrace Logo

The Impact of Vitamin D on Disease Activity in Crohn's Disease

NCT01864616 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2018-05-14

No results posted yet for this study

Summary

The purpose for this study is to determine the effect of vitamin D supplementation on disease activity in Crohn's disease patients in Canada and Saudi Arabia

Conditions

  • Crohn Disease

Interventions

DIETARY_SUPPLEMENT

Vitamin D3

Sponsors & Collaborators

  • Dania Alrefai

    collaborator UNKNOWN

  • Dr.Jennifer Jones

    collaborator UNKNOWN

  • Dr.Hani Jawa

    collaborator UNKNOWN

  • Dr.Wael El-matary

    collaborator UNKNOWN

  • Saudi Arabian Cultural Bureau

    collaborator UNKNOWN

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Hassanali Vatanparast, MD,PhD · University of Saskatchewan, Saskatoon, SK,Canada

  • Jennifer Jones, MD,MSc,FRCPC · Royal University Hospital, Saskatoon, Saskatchewan, Canada

  • Hani Jawa, MBBS,ABIM,FRCPC · King Abdulaziz University, jeddah, Saudi Arabia

  • Wael El-matary, MBChB,MSc,MD,FRCPCH · University of Manitoba

  • Dania Alrefai, M.Sc · University of Saskatchewan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
16 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2015-03-31
Completion
2015-03-31

Countries

  • Canada
  • Saudi Arabia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01864616 on ClinicalTrials.gov